B. Wittig

3.4k total citations
42 papers, 2.8k citations indexed

About

B. Wittig is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, B. Wittig has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Genetics. Recurrent topics in B. Wittig's work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (6 papers). B. Wittig is often cited by papers focused on Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (6 papers). B. Wittig collaborates with scholars based in Germany, United States and Austria. B. Wittig's co-authors include Tomislav Dorbic, G. Schultz, J. Hescheler, Christiane Kleuss, Alexander Rich, Walter Rosenthal, Hans Scherübl, M. Graessmann, A. Graessmann and Stefan Wölfl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

B. Wittig

42 papers receiving 2.7k citations

Peers

Countries citing papers authored by B. Wittig

Since Specialization

Citations

This map shows the geographic impact of B. Wittig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wittig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wittig more than expected).

Fields of papers citing papers by B. Wittig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wittig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wittig. The network helps show where B. Wittig may publish in the future.

Co-authorship network of co-authors of B. Wittig

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wittig. A scholar is included among the top collaborators of B. Wittig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wittig. B. Wittig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influences of age and sex on leukocytes of healthy horses and their ex vivo cytokine release 2015 ·Veterinary Immunology and Immunopathology ·(unknown), (unknown), H. J. Schuberth, Mirja Koy, Bettina Wagner, B. Wittig, (unknown), Saskia Willenbrock, Hugo Murua Escobar, (unknown), Karsten Feige, Jessika‐M. V. Cavalleri	14
2	Safety data of MGN1601, a tumor vaccine, made of allogeneic, transfected, and irradiated tumor cells in combination with an immunomodulator for the treatment of metastatic renal cell carcinoma. 2010 ·Journal of Clinical Oncology ·Manuel Schmidt, (unknown), Matthias Schroff, (unknown), Christiane Kleuss, Marina Tschaika, B. Wittig	1
3	SuperPred: drug classification and target prediction 2008 ·Nucleic Acids Research ·Mathias Dunkel, Stefan Günther, Jessica Ahmed, B. Wittig, Robert Preißner	137
4	Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long‐term remission in patients with steroid‐refractory Crohn's disease 2006 ·Alimentary Pharmacology & Therapeutics ·Carsten Schmidt, B. Wittig, (unknown), Martin Zeitz, Andreas Stallmach	20
5	ClustDB: A High-Performance Tool for Large Scale Sequence Matching 2006 ·J. Kleffe, (unknown), B. Wittig	3
6	An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn’s disease and experimental colitis in vivo 2004 ·Gut ·Andreas Stallmach, Thomas Marth, (unknown), B. Wittig, Andreas Hombach, Carsten Schmidt, MF Neurath, Martin Zeitz, Stefan Zeuzem, Hinrich Abken	51
7	Proliferation-dependent induction of apoptosis by the retinoid CD437 in p53-mutated keratinocytes 2002 ·Journal of Molecular Medicine ·R. Wanner, (unknown), B. Wittig, G. Kolde	11
8	DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice 2002 ·Vaccine ·Laura López-Fuertes, Eva Pérez-Jiménez, Antonio J. Vila‐Coro, (unknown), Sonia Carreño-Moreno, (unknown), Claas Junghans, B. Wittig, Marcos Timón, Mariano Estéban	58
9	Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs 2001 ·Cancer Gene Therapy ·Angela Märten, Carsten Ziske, Björn Schöttker, (unknown), Sabine Renoth, Peter Buttgereit, Frank Schakowski, Sven König, Alexander von Rücker, Axel Alléra, Roland Schroers, Tilman Sauerbruch, B. Wittig, Ingo G.H. Schmidt‐Wolf	13
10	Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation 2000 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown), (unknown), B. Wittig, Friedrich Hoffmann	37
11	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma 1999 ·British Journal of Cancer ·Ingo Schmidt‐Wolf, Sebastian Finke, Beate Trojaneck, (unknown), Petja Lefterova, N. Schwella, (unknown), (unknown), (unknown), Motohiro Takeya, Tomislav Dorbic, Andreas Neubauer, B. Wittig, D. Huhn	180
12	Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study 1998 ·Gene Therapy ·Yuansheng Sun, K Jurgovsky, Peter Möller, Selma Alijagic, Tomislav Dorbic, (unknown), B. Wittig, Dirk Schadendorf	125
13	Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene 1998 ·Gene Therapy ·Sebastian Finke, Beate Trojaneck, Petja Lefterova, (unknown), Ernst Wagner, Ralf Kircheis, Andreas Neubauer, D. Huhn, B. Wittig, (unknown)	37
14	Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study 1998 ·British Journal of Cancer ·Peter Möller, Yuansheng Sun, Tomislav Dorbic, Selma Alijagic, (unknown), K Jurgovsky, Matthias Schroff, (unknown), B. Wittig, Dirk Schadendorf	69
15	Simple and Sensitive Detection of Mutations in the Ras Proto-Oncogenes Using PNA-Mediated PCR Clamping 1996 ·Nucleic Acids Research ·Christian Thiede, E. Bayerdörffer, Rainer Blasczyk, B. Wittig, Andreas Neubauer	97
16	DNASTAT: a Pascal unit for the statistical analysis of DNA and protein sequences 1995 ·Computer applications in the biosciences ·J. Kleffe, Klaus Hermann, (unknown), Wolfgang Vahrson, B. Wittig	2
17	Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma 1995 ·Journal of Molecular Medicine ·Dirk Schadendorf, B. M. Czarnetzki, B. Wittig	15
18	Effect of netropsin, distamycin A and chromomycin A₃ on the binding and cleavage reaction of DNA gyrase 1994 ·FEBS Letters ·(unknown), B. Wittig, Christoph Zimmer	13
19	Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents 1991 ·Nature ·Christiane Kleuss, J. Hescheler, (unknown), Walter Rosenthal, G. Schultz, B. Wittig	496
20	Lack of correlation between DNA methylation and transcriptional inactivation: the chicken lysozyme gene. 1991 ·Proceedings of the National Academy of Sciences ·Stefan Wölfl, M. Schrader, B. Wittig	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact